Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study

DSpace Repository

Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study

Author: Weide, Benjamin; Martens, Alexander; Wistuba-Hamprecht, Kilian; Zelba, Henning; Maier, Ludwig; Lipp, Hans-Peter; Klumpp, Bernhard D.; Soffel, Daniel; Eigentler, Thomas K.; Garbe, Claus
Tübinger Autor(en):
Weide, Benjamin Matthias
Martens, Alexander
Wistuba-Hamprecht, Kilian
Zelba, Henning
Lipp, Hans-Peter
Soffel, Daniel
Garbe, Claus
Klumpp, Bernhard
Eigentler, Thomas Kurt
Published in: Cancer Immunology Immunotherapy (2017), Bd. 66, H. 4, S. 441-449
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00262-016-1944-0
ISSN: 1432-0851
DDC Classifikation: 610 - Medicine and health
570 - Life sciences; biology
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)